<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cancer on Raunak Shrestha</title>
    <link>/tags/cancer/</link>
    <description>Recent content in Cancer on Raunak Shrestha</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year} Raunak Shrestha</copyright>
    <lastBuildDate>Thu, 05 Dec 2024 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="/tags/cancer/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer</title>
      <link>/publication/2024_mhc/</link>
      <pubDate>Thu, 05 Dec 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_mhc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer</title>
      <link>/publication/2024_prepost/</link>
      <pubDate>Tue, 13 Aug 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_prepost/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression</title>
      <link>/publication/2024_wcdt_atacseq/</link>
      <pubDate>Thu, 11 Jul 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_wcdt_atacseq/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Thrilled! Our study &amp;quot;An Atlas of Accessible Chromatin in Advanced Prostate Cancer..&amp;quot; is now online &lt;a href=&#34;https://twitter.com/CR_AACR?ref_src=twsrc%5Etfw&#34;&gt;@CR_AACR&lt;/a&gt;&lt;br&gt;Thank you &lt;a href=&#34;https://twitter.com/felixfengmd?ref_src=twsrc%5Etfw&#34;&gt;@felixfengmd&lt;/a&gt; &lt;a href=&#34;https://twitter.com/David_A_Quigley?ref_src=twsrc%5Etfw&#34;&gt;@David_A_Quigley&lt;/a&gt; &lt;a href=&#34;https://twitter.com/MatLupien?ref_src=twsrc%5Etfw&#34;&gt;@MatLupien&lt;/a&gt; for amazing mentorship &amp;amp; &lt;a href=&#34;https://twitter.com/PCF_Science?ref_src=twsrc%5Etfw&#34;&gt;@PCF_science&lt;/a&gt;, the Benioff Institute, &lt;a href=&#34;https://twitter.com/UCSFCancer?ref_src=twsrc%5Etfw&#34;&gt;@UCSFCancer&lt;/a&gt; for their support! &lt;a href=&#34;https://t.co/O2zTlzCsqh&#34;&gt;https://t.co/O2zTlzCsqh&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha, PhD (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1811506881405550716?ref_src=twsrc%5Etfw&#34;&gt;July 11, 2024&lt;/a&gt;&lt;/blockquote&gt; &lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;</description>
    </item>
    
    <item>
      <title>Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer</title>
      <link>/publication/2024_wcdt_hic/</link>
      <pubDate>Sun, 09 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_wcdt_hic/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression</title>
      <link>/publication/2024_alternative_promoter/</link>
      <pubDate>Sun, 09 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>/publication/2024_alternative_promoter/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The genomic and epigenomic landscape of double-negative metastatic prostate cancer</title>
      <link>/publication/2023_dnpc/</link>
      <pubDate>Thu, 08 Jun 2023 00:00:00 +0000</pubDate>
      
      <guid>/publication/2023_dnpc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The 5-Hydroxymethylcytosine Landscape of Prostate Cancer</title>
      <link>/publication/2022_prostate5hmc/</link>
      <pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate>
      
      <guid>/publication/2022_prostate5hmc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer</title>
      <link>/publication/2021_prostatecrispr/</link>
      <pubDate>Fri, 30 Jul 2021 00:00:00 +0000</pubDate>
      
      <guid>/publication/2021_prostatecrispr/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability</title>
      <link>/publication/2021_lgsoc/</link>
      <pubDate>Thu, 14 Jan 2021 00:00:00 +0000</pubDate>
      
      <guid>/publication/2021_lgsoc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Autoantibody landscape in patients with advanced prostate cancer</title>
      <link>/publication/2020_prostateab/</link>
      <pubDate>Wed, 23 Sep 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_prostateab/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Identification of Conserved Evolutionary Trajectories in Tumors</title>
      <link>/publication/2020_conett/</link>
      <pubDate>Mon, 13 Jul 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_conett/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Delighted to share our paper describing an algorithm CONETT to identify Conserved Evolutionary Trajectory Tree from multiple tumors. This paper will be presented at the &lt;a href=&#34;https://twitter.com/hashtag/ISMB2020?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#ISMB2020&lt;/a&gt; conference next week. &lt;a href=&#34;https://twitter.com/cenksahinalp?ref_src=twsrc%5Etfw&#34;&gt;@cenksahinalp&lt;/a&gt; &lt;a href=&#34;https://t.co/9uMAoaPDoQ&#34;&gt;https://t.co/9uMAoaPDoQ&lt;/a&gt; &lt;a href=&#34;https://t.co/uV1NO23tDe&#34;&gt;pic.twitter.com/uV1NO23tDe&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1283257549697896448?ref_src=twsrc%5Etfw&#34;&gt;July 15, 2020&lt;/a&gt;&lt;/blockquote&gt; &lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
</description>
    </item>
    
    <item>
      <title>Y-box Binding Protein-1 is Crucial in Acquired Drug Resistance Development in Metastatic Clear-Cell Renal Cell Carcinoma</title>
      <link>/publication/2020_ybox/</link>
      <pubDate>Mon, 10 Feb 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_ybox/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Identification of Predictive Gene Signature to Guide Precision Oncology of Clear-Cell Renal Cell Carcinoma</title>
      <link>/publication/2020_rcc/</link>
      <pubDate>Thu, 06 Feb 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_rcc/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pan-cancer Analysis of Whole Genomes</title>
      <link>/publication/2020_pcawg_nature/</link>
      <pubDate>Wed, 05 Feb 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_pcawg_nature/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Great to co-author this landmark paper from the Pan-Cancer Analysis of Whole Genomes &lt;a href=&#34;https://twitter.com/hashtag/PCWAG?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#PCWAG&lt;/a&gt; consortium published today in Nature &lt;a href=&#34;https://t.co/pn5gwNYwHo&#34;&gt;https://t.co/pn5gwNYwHo&lt;/a&gt; &lt;a href=&#34;https://t.co/ea39L5OiHu&#34;&gt;https://t.co/ea39L5OiHu&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1225204053379928064?ref_src=twsrc%5Etfw&#34;&gt;February 5, 2020&lt;/a&gt;&lt;/blockquote&gt; &lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
</description>
    </item>
    
    <item>
      <title>Pathway and network analysis of more than 2,500 whole cancer genomes</title>
      <link>/publication/2020_pcawg_network/</link>
      <pubDate>Wed, 05 Feb 2020 00:00:00 +0000</pubDate>
      
      <guid>/publication/2020_pcawg_network/</guid>
      <description></description>
    </item>
    
    <item>
      <title>BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma</title>
      <link>/publication/2019_mesothelioma/</link>
      <pubDate>Thu, 07 Feb 2019 00:00:00 +0000</pubDate>
      
      <guid>/publication/2019_mesothelioma/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34; data-lang=&#34;en&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Our paper describing a potentially new treatment for Peritoneal &lt;a href=&#34;https://twitter.com/hashtag/Mesothelioma?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Mesothelioma&lt;/a&gt; published today in &lt;a href=&#34;https://twitter.com/GenomeMedicine?ref_src=twsrc%5Etfw&#34;&gt;@GenomeMedicine&lt;/a&gt;  &lt;a href=&#34;https://t.co/admejVvX5K&#34;&gt;https://t.co/admejVvX5K&lt;/a&gt; &lt;a href=&#34;https://twitter.com/VanProstateCtr?ref_src=twsrc%5Etfw&#34;&gt;@VanProstateCtr&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/PrecisionOncology?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#PrecisionOncology&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Immunotherapy?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Immunotherapy&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Cancer?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Cancer&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Genomics?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Genomics&lt;/a&gt; (1/n) &lt;a href=&#34;https://t.co/mWrsjpTsr1&#34;&gt;pic.twitter.com/mWrsjpTsr1&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1097516525865431041?ref_src=twsrc%5Etfw&#34;&gt;February 18, 2019&lt;/a&gt;&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
&lt;blockquote class=&#34;twitter-tweet&#34; data-lang=&#34;en&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Great to see our work ( &lt;a href=&#34;https://t.co/admejVvX5K&#34;&gt;https://t.co/admejVvX5K&lt;/a&gt; ) making a mark in the field. Thanks &lt;a href=&#34;https://twitter.com/MLadanyi?ref_src=twsrc%5Etfw&#34;&gt;@MLadanyi&lt;/a&gt; &lt;a href=&#34;https://twitter.com/fsanchezvega?ref_src=twsrc%5Etfw&#34;&gt;@fsanchezvega&lt;/a&gt; &lt;a href=&#34;https://twitter.com/MGZauderer?ref_src=twsrc%5Etfw&#34;&gt;@MGZauderer&lt;/a&gt; for highlighting our work.  &lt;a href=&#34;https://t.co/s1cTVs2TgD&#34;&gt;https://t.co/s1cTVs2TgD&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Mesothelioma?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Mesothelioma&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/PeritonealMesothelioma?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#PeritonealMesothelioma&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Immunotherapy?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Immunotherapy&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1110969391925989377?ref_src=twsrc%5Etfw&#34;&gt;March 27, 2019&lt;/a&gt;&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
</description>
    </item>
    
    <item>
      <title>Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks</title>
      <link>/publication/2019_cdcap/</link>
      <pubDate>Tue, 05 Feb 2019 00:00:00 +0000</pubDate>
      
      <guid>/publication/2019_cdcap/</guid>
      <description>&lt;blockquote class=&#34;twitter-tweet&#34; data-lang=&#34;en&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Our latest publication in &lt;a href=&#34;https://twitter.com/GigaScience?ref_src=twsrc%5Etfw&#34;&gt;@GigaScience&lt;/a&gt; on an algorithm to identify patterns of similarity of molecular alterations between cancer patients. “Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks” &lt;a href=&#34;https://twitter.com/hashtag/Bioinformatics?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Bioinformatics&lt;/a&gt; &lt;a href=&#34;https://t.co/V1MgtqOLkL&#34;&gt;https://t.co/V1MgtqOLkL&lt;/a&gt; &lt;a href=&#34;https://t.co/IRcUVtbnIG&#34;&gt;pic.twitter.com/IRcUVtbnIG&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/1116426582350974976?ref_src=twsrc%5Etfw&#34;&gt;April 11, 2019&lt;/a&gt;&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
</description>
    </item>
    
    <item>
      <title>HIT&#39;nDRIVE: Patient-Specific Multi-Driver Gene Prioritization for Precision Oncology</title>
      <link>/publication/2017_hitndrive/</link>
      <pubDate>Tue, 18 Jul 2017 00:00:00 +0000</pubDate>
      
      <guid>/publication/2017_hitndrive/</guid>
      <description>&lt;iframe width=&#34;560&#34; height=&#34;315&#34; src=&#34;https://www.youtube.com/embed/29zZoYLDnwk&#34; frameborder=&#34;0&#34; allowfullscreen&gt;&lt;/iframe&gt;
&lt;iframe width=&#34;560&#34; height=&#34;315&#34; src=&#34;https://www.youtube.com/embed/Ty3kgTCW9mQ&#34; frameborder=&#34;0&#34; allowfullscreen&gt;&lt;/iframe&gt;
&lt;blockquote class=&#34;twitter-tweet&#34; data-lang=&#34;en&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Here goes my paper that got published in &lt;a href=&#34;https://twitter.com/genomeresearch?ref_src=twsrc%5Etfw&#34;&gt;@genomeresearch&lt;/a&gt; today :D &lt;a href=&#34;https://t.co/yY8Ipch2Eg&#34;&gt;https://t.co/yY8Ipch2Eg&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Bioinformatics?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Bioinformatics&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Genomics?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Genomics&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/PrecisionOncology?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#PrecisionOncology&lt;/a&gt; &lt;a href=&#34;https://t.co/ZxDCjzrQn6&#34;&gt;pic.twitter.com/ZxDCjzrQn6&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/887438687427936257?ref_src=twsrc%5Etfw&#34;&gt;July 18, 2017&lt;/a&gt;&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
&lt;blockquote class=&#34;twitter-tweet&#34; data-lang=&#34;en&#34;&gt;&lt;p lang=&#34;en&#34; dir=&#34;ltr&#34;&gt;Our paper highlighted in &lt;a href=&#34;https://twitter.com/CellSystemsCP?ref_src=twsrc%5Etfw&#34;&gt;@CellSystemsCP&lt;/a&gt;  &amp;quot;Identifying Rare Cancer Drivers&amp;quot; &lt;a href=&#34;https://t.co/5ob895KjS4&#34;&gt;https://t.co/5ob895KjS4&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/Bioinformatics?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#Bioinformatics&lt;/a&gt; &lt;a href=&#34;https://twitter.com/hashtag/precisionmedicine?src=hash&amp;amp;ref_src=twsrc%5Etfw&#34;&gt;#precisionmedicine&lt;/a&gt; &lt;a href=&#34;https://t.co/pW3rZuNneo&#34;&gt;pic.twitter.com/pW3rZuNneo&lt;/a&gt;&lt;/p&gt;&amp;mdash; Raunak Shrestha (@raunakms) &lt;a href=&#34;https://twitter.com/raunakms/status/900429909570363392?ref_src=twsrc%5Etfw&#34;&gt;August 23, 2017&lt;/a&gt;&lt;/blockquote&gt;
&lt;script async src=&#34;https://platform.twitter.com/widgets.js&#34; charset=&#34;utf-8&#34;&gt;&lt;/script&gt;
</description>
    </item>
    
    <item>
      <title>BIRC6-targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer</title>
      <link>/publication/2016_birc6/</link>
      <pubDate>Fri, 23 Sep 2016 00:00:00 +0000</pubDate>
      
      <guid>/publication/2016_birc6/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer</title>
      <link>/publication/2014_highriskpca/</link>
      <pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate>
      
      <guid>/publication/2014_highriskpca/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines</title>
      <link>/publication/2014_drugresp/</link>
      <pubDate>Fri, 18 Jul 2014 00:00:00 +0000</pubDate>
      
      <guid>/publication/2014_drugresp/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
